[
  {
    "ts": null,
    "headline": "2 Healthcare Dividend Stocks to Buy and Hold",
    "summary": "These drugmakers have competitive yields and have increased their dividends at a good clip.",
    "url": "https://finnhub.io/api/news?id=cce71d36cf5df4a7be8688d4e0c8c49f74ece8b361ce1db1518c1f7c54cf4a67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757852100,
      "headline": "2 Healthcare Dividend Stocks to Buy and Hold",
      "id": 136741693,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "These drugmakers have competitive yields and have increased their dividends at a good clip.",
      "url": "https://finnhub.io/api/news?id=cce71d36cf5df4a7be8688d4e0c8c49f74ece8b361ce1db1518c1f7c54cf4a67"
    }
  },
  {
    "ts": null,
    "headline": "Amgen: Buy The Dip Opportunity",
    "summary": "Amgen trades below historical multiples despite strong Q2 results, a robust pipeline, and a 3.4% yield, offering value. Check out why AMGN stock is a buy.",
    "url": "https://finnhub.io/api/news?id=c880b3ecb82ba883bf2bdac9a9646abb79ef7f035d9251911e832edd7751eced",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757838638,
      "headline": "Amgen: Buy The Dip Opportunity",
      "id": 136740967,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1289941019/image_1289941019.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen trades below historical multiples despite strong Q2 results, a robust pipeline, and a 3.4% yield, offering value. Check out why AMGN stock is a buy.",
      "url": "https://finnhub.io/api/news?id=c880b3ecb82ba883bf2bdac9a9646abb79ef7f035d9251911e832edd7751eced"
    }
  },
  {
    "ts": null,
    "headline": "Guggenheim Maintains a Hold on Amgen Inc. (AMGN)",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best cheap stocks to buy for beginners. In a report released on September 5, Vamil Divan from Guggenheim maintained a Hold rating on Amgen Inc. (NASDAQ:AMGN), setting a price target of $288.00. Amgen Inc. (NASDAQ:AMGN) reported its fiscal Q2 2025 earnings on August 5, with t0tal revenues increasing […]",
    "url": "https://finnhub.io/api/news?id=d2f3473398673dc6663072f83c5e5abdc9573faa45ce3391a3a4248505575f44",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757830629,
      "headline": "Guggenheim Maintains a Hold on Amgen Inc. (AMGN)",
      "id": 136741713,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the best cheap stocks to buy for beginners. In a report released on September 5, Vamil Divan from Guggenheim maintained a Hold rating on Amgen Inc. (NASDAQ:AMGN), setting a price target of $288.00. Amgen Inc. (NASDAQ:AMGN) reported its fiscal Q2 2025 earnings on August 5, with t0tal revenues increasing […]",
      "url": "https://finnhub.io/api/news?id=d2f3473398673dc6663072f83c5e5abdc9573faa45ce3391a3a4248505575f44"
    }
  }
]